-DNA 38 districts under Green Revolution II affected by slow poison Indian government's ambitious project Green Revolution-II (GR-II) to promote growing rice in the Eastern states of India is bringing arsenic to your plates. As many as 38 districts spreading across six states out of the seven states where the scheme is being implemented are reported to be affected by arsenic. These states are Bihar, West Bengal, Assam, Eastern Uttar Pradesh, Jharkhand...

-Frontline Kerala is facing a situation where health care costs are leading more and more people, not just low-income families, to financial distress. KERALA is once again drawing attention to itself, this time for a persistent trend of a large number of households being pushed into financial ruin because of the expenses incurred for medical care. Several studies have now found evidence for the many facets of this worrying development in a...

-Economic and Political Weekly Since independence, India's national health policies have been aspirational but the end results have been limited. The National Health Policy 2015, which is in the process of being finalised, should, in place of the earlier "broadband" approach, adopt a "narrow focus" on primary healthcare through the National Rural Health Mission. The latter has focused on primary healthcare and has shown visible results. A slew of suggestions as...

-The Telegraph New Delhi: International health activists have joined their Indian counterparts in decrying what they say are Barack Obama's dual policy on big drug companies, pledging to break their stranglehold in the US but promoting their interests in India. The activists claimed yesterday that the India-US joint statement, issued during Obama's visit to India, contains signals that the Indian government could be preparing to weaken its intellectual property regulations on medicines,...

-The Telegraph New Delhi: Health and patients' rights groups have called on the government to resist American pressure that they claimed was aimed at weakening safeguards in India's patent laws that allow drug companies to sell inexpensive generic medicine. Health activists representing patients' rights said they were concerned that bilateral talks on intellectual property rights, to feature during US President Barack Obama's visit to India beginning this weekend, may be rigged against...